Chemours has completed its planned procedures with respect to an internal review that it first announced on 29 February. This essentially confirmed the details revealed in an interim report on 7 March. More will be published in the compensation discussion and analysis in the proxy statement for the 2024 annual meeting.

The Audit Committee of the Chemours board has delivered a “substantially complete” report of the findings of the internal review it was tasked to complete with regard to the conduct of CEO Mark Newman, CFO Jonathan Lock and principal accounting officer Camela Wisel. All three were put on administrative leave on 29 February pending its completion.

The board of Chemours has put CEO Mark Newman, CFO Jonathan Lock and principal accounting officer Camela Wisel on administrative leave pending the completion of an internal review by independent counsel that the board’s audit committee is overseeing.

During its Q2 results presentation, Chemours announced a decision to close its Kuan Yin TiO₂ manufacturing facility in Taiwan (pictured). The firm described this as “part of a comprehensive strategy to improve the earnings quality of TT – producers of the popular Ti-Pure brand – by optimising its manufacturing circuit”.